Cidara Therapeutics Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa)

This study tests whether giving a high-dose flu vaccine together with a new long-acting antiviral drug (CD388) is safe and does not weaken the body's immune response. About 100 healthy adults aged 18 to 49 will receive either the vaccine plus CD388 or the vaccine plus a placebo. …

This study looks at whether giving a new experimental drug called CD388 once a year for two years is safe in healthy adults who have already received one dose without major side effects. About 400 participants will get two doses and be monitored for 18 months. Researchers will ch…

This study is testing whether a new long-acting antiviral injection called CD388 can prevent people from getting the flu. It will involve about 7,500 adults and teenagers who are at higher risk for serious flu complications. Participants will receive either the real injection or …